MedPath

The Effects of Morphine on Desflurane Consumption and Recovery Time

Phase 4
Completed
Conditions
Abdominal Hysterectomy (& Wertheim)
Interventions
Registration Number
NCT02362022
Lead Sponsor
Baskent University
Brief Summary

Combination of volatile and opioid agents are used to achieve unconsciousness, haemodynamic stability and analgesia for surgical prosedures. This prospective, randomized, double-blind, controlled study evaluates the effects of two different doses of morphine sulphate (0.1 mg/kg and 0.2 mg/kg), on desflurane consumption, recovery characteristics, postoperative analgesic requirements and side effects during total abdominal hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • undergoing total abdominal hysterectomy with general anaesthesia
Exclusion Criteria
  • renal dysfunction (cre>1.2), liver failure, cardiovascular, psychiatric, allergic and metabolic disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group Morphine 1MorphineGroup Morphine 1 (Group M1) received i.v morphine 0.1 mg kg-1, in 10 ml volume (n=30)
Group SalineMorphineGroup Saline (Group S) received i.v saline 0.9 % in 10 ml volume (n=30)
Group Morphine 2MorphineGroup Morphine 2 (Group M2) received i.v morphine 0.2 mg kg-1, in 10 ml volume (n=30)
Primary Outcome Measures
NameTimeMethod
postoperative desflurane consumptionpostoperative first hour
sedation scores for OASS scalepostoperative first hour
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Baskent University School of Medicine Adana Teaching and Research Hospital

🇹🇷

Adana, Turkey

© Copyright 2025. All Rights Reserved by MedPath